ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PYC Physiomics Plc

1.60
0.10 (6.67%)
Last Updated: 12:58:54
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00BDR6W943 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.10 6.67% 1.60 1.50 1.70 1.60 1.50 1.50 531,136 12:58:54
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 597k -477k -0.0035 -4.29 2.03M
Physiomics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker PYC. The last closing price for Physiomics was 1.50p. Over the last year, Physiomics shares have traded in a share price range of 0.925p to 3.15p.

Physiomics currently has 135,472,478 shares in issue. The market capitalisation of Physiomics is £2.03 million. Physiomics has a price to earnings ratio (PE ratio) of -4.29.

Physiomics Share Discussion Threads

Showing 27351 to 27368 of 30125 messages
Chat Pages: Latest  1097  1096  1095  1094  1093  1092  1091  1090  1089  1088  1087  1086  Older
DateSubjectAuthorDiscuss
16/10/2020
08:33
Of course. Had they put out figures then i wouldn't have
spacedust
16/10/2020
08:18
You've changed your tune!

spacedust - 22 Jul 2020 - 08:16:28 - 28521 of 35007
 you are looking for another ncyt like riser then take a look at

PYC

10p now couod well go to 100p plus

bountyhunter
16/10/2020
08:12
Or even today. Disgraceful management
spacedust
16/10/2020
08:08
Will be red next weekbelow todays starting price of 6.75p
spacedust
16/10/2020
08:07
Shareholders in the dark yet again whilst jim the cunning really knows the value. Shareholders not respected at all. Treating us like garbage as usual
spacedust
16/10/2020
07:51
Undisclosed value yst again. What a load of shttt
spacedust
16/10/2020
07:31
Another project of roughly 70k Nd extension of existing which is also around 80k ,so roughly 150k (my own calculation from industry standard rates and AVG from their previous rates ) Two more contract in pipeline what I heard off .Dyor
tmmalik
16/10/2020
07:25
Up day today! 🙂
bountyhunter
15/10/2020
12:30
Rose tinted thread must be getting worried.
albert3591
15/10/2020
12:06
Rampers needed,but they won’t help at all.
albert3591
15/10/2020
10:19
Like i said..
albert3591
15/10/2020
08:29
Pyc..heading for cash generation and it also has an interest in the future of a or some of SAR.s products.
Sar has been moving up recently.

bobdown2
14/10/2020
17:22
2small up days =1 big down day tomorrow.
albert3591
14/10/2020
15:06
Unusual for stiggy to get so exited,pyc must be on its way down soon.You gotta feel for stiggy.lol
albert3591
14/10/2020
15:01
Cancer Research UK and NCI (US National Cancer Institute) are running Cancer Grand Challenge project

Interestingly PYC Chairman specifically mentioned Cancer Research UK project in first paragraph of his Final Results comments :

"Dr Paul Harper, Non-Executive Chairman, commented:

"The Company continues to make good progress, with all key indicators of performance moving in the right direction. We are pleased to be working with Cancer Research UK (announced July 2019) and to have repeat contracts with both CellCentric and Bicycle Therapeutics, as well as our first contract with Astellas Pharma Inc."

I expect Physiomics could apply for multiple project streams in this Competition alongside other teams they've worked with in the past

ICR and Royal Marsden NHS (NIHR)
Oxford University and Oxford NHS (OAHSN)

the stigologist
14/10/2020
14:02
WOW !!!



Why treatment regimens?

While some cancer cells are killed by treatment, others can survive. This is why some cancers can come back. The cancer cells that aren’t destroyed can continue to grow, forming a tumour again.

To get around this, doctors often give different treatments in combination. But it’s not always clear which combination is best, or how much of each treatment to give, or when the different treatments should be given.

This Cancer Grand Challenge aims to find clear answers to those questions by improving our understanding of combination treatments. If we better understand how treatments work together, we can make sure patients get the best combinations for their disease. And we might be able to predict how a patient’s cancer will respond to particular treatments, so we can tailor the approach and stay one step ahead of the disease.

the stigologist
14/10/2020
13:59
£20m cheque with Physiomics name on it...



Who will solve cancer’s most complex challenges?

The nine new challenges are now open for applications. Submit your expression of interest (EOI) before 22 April 2021.

Find everything you need to apply for the current round of challenges

Successful teams will each receive £20m (c.$25m) to carry out team science on a global scale.

the stigologist
14/10/2020
13:23
Is anyone alive out there........Load of pants
justtrying1
Chat Pages: Latest  1097  1096  1095  1094  1093  1092  1091  1090  1089  1088  1087  1086  Older

Your Recent History

Delayed Upgrade Clock